imatinib mesylate has been researched along with Abscess in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abu-Gazala, M; Almogy, G; Appelbaum, L; Bala, M; Elazary, R; Khalaileh, A; Khatib, A; Neuman, T; Rivkind, AI; Schlager, A | 1 |
| Selleslag, D | 1 |
1 review(s) available for imatinib mesylate and Abscess
| Article | Year |
|---|---|
Malignant appendiceal GIST: case report and review of the literature.
Topics: Abscess; Antineoplastic Agents; Appendiceal Neoplasms; Benzamides; Diabetes Mellitus, Type 2; Gastrointestinal Stromal Tumors; Humans; Hypertension; Imatinib Mesylate; Immunohistochemistry; Male; Middle Aged; Neoadjuvant Therapy; Piperazines; Pyrimidines; Tomography, X-Ray Computed | 2010 |
1 other study(ies) available for imatinib mesylate and Abscess
| Article | Year |
|---|---|
A case of fusariosis in an immunocompromised patient successfully treated with liposomal amphotericin B.
Topics: Abscess; Amphotericin B; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Combined Modality Therapy; Cytarabine; Foot Dermatoses; Fusarium; Humans; Imatinib Mesylate; Immunocompromised Host; Liposomes; Male; Middle Aged; Muscular Diseases; Onychomycosis; Peripheral Blood Stem Cell Transplantation; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Recurrence; Remission Induction; Reoperation; Rituximab; Teniposide; Triazoles; Voriconazole | 2006 |